ARA-290 vs KPV

ARA-290

ARA-290, also known as cibinetide, is a small peptide derived from the structure of erythropoietin that selectively engages the innate repair receptor (a heteromer of the EPO receptor and the CD131 beta-common receptor) without stimulating erythropoiesis. Research has explored its role in modulating inflammatory cascades, supporting neuronal and vascular tissue under stress, and influencing pain pathways associated with small-fiber neuropathy. Because it does not raise hematocrit, it has been investigated as a tool for studying tissue-protective EPO signaling in isolation. This compound is supplied as a lyophilized powder for in-vitro and laboratory research use only and is not intended for human or veterinary use.

KPV

KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), specifically positions 11-13. Despite being only three amino acids, KPV retains the potent anti-inflammatory activity of the full-length hormone while lacking melanotropic and steroidogenic effects. KPV suppresses inflammation by inhibiting NF-kB nuclear translocation and reducing pro-inflammatory cytokine production, including IL-1beta, IL-6, and TNF-alpha. It enters cells and interacts directly with inflammatory signaling cascades independently of melanocortin receptors. Research published in the Journal of Biological Chemistry by Brzoska et al. demonstrated that KPV inhibited NF-kB activation in human intestinal epithelial cells, reducing inflammatory gene expression by 60-80% at micromolar concentrations. Studies in murine colitis models published in Inflammatory Bowel Diseases showed that oral and intracolonic KPV use significantly reduced disease activity index scores, colonic inflammation, and histological damage. Dalmasso et al. (2008) in PLoS ONE confirmed that KPV-loaded nanoparticles effectively targeted inflamed colonic tissue and accelerated mucosal healing. Compared to full-length alpha-MSH, KPV offers the advantage of anti-inflammatory activity without pigmentation effects or hormonal side effects. Unlike conventional anti-inflammatory agents such as corticosteroids or NSAIDs, KPV targets intracellular NF-kB signaling rather than cyclooxygenase or glucocorticoid receptor pathways, representing a mechanistically distinct approach to inflammation modulation. Store lyophilized KPV at -20°C. Reconstitute with bacteriostatic water and refrigerate at 2-8°C, using within 4 weeks. KPV is researched by gastroenterologists studying inflammatory bowel disease, dermatologists investigating anti-inflammatory skin treatments, and immunologists examining NF-kB-dependent inflammatory pathways.

Frequently Asked Questions